Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Swain

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|June 3, 1993
In situ or localized breast cancer--how much treatment is needed?S M Swain
The Surgical Clinics of North America|October 1, 1990
Selection of therapy for stage III breast cancerS M Swain
Seminars in Oncology|October 13, 1998
Adult multicenter trials using dexrazoxane to protect against cardiac toxicityS M Swain
Oncology (Williston Park, N.Y.)|March 1, 1989
Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatmentS M Swain
The New England Journal of Medicine|February 27, 1999
Doxorubicin-induced cardiomyopathyS M Swain
Journal of the National Cancer Institute|July 5, 2001
Tamoxifen and contralateral breast cancer: the other sideS M Swain
Cancer Investigation|January 1, 1992
Ductal carcinoma in situS M Swain
Cancer Investigation|April 1, 1999
Locally advanced noninflammatory breast cancerS M Swain
Journal of the National Cancer Institute|November 6, 1996
Tamoxifen: the long and short of itS M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Tamoxifen for patients with estrogen receptor-negative breast cancerS M Swain
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|June 3, 1993
In situ or localized breast cancer--how much treatment is needed?S M Swain
The Surgical Clinics of North America|October 1, 1990
Selection of therapy for stage III breast cancerS M Swain
Seminars in Oncology|October 13, 1998
Adult multicenter trials using dexrazoxane to protect against cardiac toxicityS M Swain
Oncology (Williston Park, N.Y.)|March 1, 1989
Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatmentS M Swain
The New England Journal of Medicine|February 27, 1999
Doxorubicin-induced cardiomyopathyS M Swain
Journal of the National Cancer Institute|July 5, 2001
Tamoxifen and contralateral breast cancer: the other sideS M Swain
Cancer Investigation|January 1, 1992
Ductal carcinoma in situS M Swain
Cancer Investigation|April 1, 1999
Locally advanced noninflammatory breast cancerS M Swain
Journal of the National Cancer Institute|November 6, 1996
Tamoxifen: the long and short of itS M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2001
Tamoxifen for patients with estrogen receptor-negative breast cancerS M Swain
Pageof 8